Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety

Biomarker-Driven Early Clinical Trials in Oncology

(2010) Daniel S. W. Tan et al.   CANCER JOURNAL

Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents

(2010) J. E. Dancey et al.   CLINICAL CANCER RESEARCH

Ethics of Mandatory Research Biopsy for Correlative End Points Within Clinical Trials in Oncology

(2010) Jeffrey Peppercorn et al.   JOURNAL OF CLINICAL ONCOLOGY

Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study

(2010) Josep Tabernero et al.   JOURNAL OF CLINICAL ONCOLOGY

Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study

(2010) G. Locatelli et al.   MOLECULAR CANCER THERAPEUTICS

Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment

(2010) Nathalie Lassau et al.   Targeted Oncology

Translational research in phase I trials

(2009) Angelica Fasolo et al.   Clinical & Translational Oncology

Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?

(2009) Craig P. Carden et al.   DRUG DISCOVERY TODAY

Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials

(2009) Hendrik-Tobias Arkenau et al.   JOURNAL OF CLINICAL ONCOLOGY

Performing Nondiagnostic Research Biopsies in Irradiated Tissue: A Review of Scientific, Clinical, and Ethical Considerations

(2008) Aaron P. Brown et al.   JOURNAL OF CLINICAL ONCOLOGY

Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors

(2008) Josep Tabernero et al.   JOURNAL OF CLINICAL ONCOLOGY